ASX · BIT.AX
Biotron Limited
A$0.00A$0.00 (0.0%)
Biotron Limited’s quoted price sits in the lower half of its reported 52-week range, 60.0% below the high.
Loading market information…
OTC · PFND · USD
Stock price
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Pathfinder Cell Therapy, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Pathfinder Cell Therapy, Inc. is an emerging biotechnology firm specializing in regenerative medicine. This company is dedicated to pioneering innovative cell-based and associated treatments designed to address a range of illnesses and health issues, particularly those involving localized cellular injury within organs. Its proprietary technology shows promise for tackling conditions such as diabetes, kidney disease, heart attacks (myocardial infarction), and peripheral vascular ailments, among others. Established in 2008, the company maintains its corporate headquarters in Cambridge, Massachusetts.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:54 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
A$0.00A$0.00 (0.0%)
Biotron Limited’s quoted price sits in the lower half of its reported 52-week range, 60.0% below the high.
€0.03-€0.00 (-1.47%)
Biophytis S.A.’s quoted price sits in the lower half of its reported 52-week range, 79.12% below the high.
$0.00$0.00 (0.0%)
RespireRx Pharmaceuticals Inc.’s quoted price sits in the upper half of its reported 52-week range, 33.33% below the high.
$0.00$0.00 (0.0%)
Therapeutic Solutions International, Inc.: Healthcare · Biotechnology.
$0.01$0.00 (0.0%)
Viracta Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 94.8% below the high.
$0.02$0.00 (0.0%)
THC Farmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 80.76% below the high.
$0.00$0.00 (-23.08%)
Regen BioPharma, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.37% below the high.
$0.00$0.00 (0.0%)
Innovation Pharmaceuticals Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.6% below the high.
